Cited by 291Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Open access

Savage, Mary J., Lin, Yin-Guo, Ciallella, John R., Flood, Dorothy G., Scott, Richard W.·2002·The Journal of Neuroscience

DOI 10.1523/jneurosci.22-09-03376.2002PMC PMC6758401

Open this paper in CoChat — free account Open PDF

Abstract

The mechanisms by which neurons and synapses are lost in Alzheimer's disease (AD) are not completely understood. To characterize potential signaling events linked to AD pathogenesis, activation-specific antibodies were used to examine mitogen-activated protein kinase (MAPK) kinase pathways at various ages in mice transgenic for human amyloid precursor protein-695 with the Swedish familial AD mutations (Tg2576) and homozygous for a P264L familial AD mutation introduced by targeting of the presenilin-1 gene (PS1(P264L)). Although the c-Jun N-terminal kinase (JNK) and p38 pathways were significantly activated in the cortex at both 7 and 12 months of age, there was no significant activation of the extracellular signal-regulated kinase pathway. MAPK kinase-4, an upstream activator of JNK, was also significantly activated at 7 and 12 months, whereas c-Jun, a downstream effector of JNK-associated apoptotic signaling, was not induced. The lack of c-Jun activation is consistent with the absence of neuronal loss in both cortex and hippocampal CA1 at 12 months. The JNK activation was localized to amyloid deposits, within neurites containing phosphorylated tau. Synaptophysin was quantified biochemically as a measure of synaptic integrity and was significantly reduced in an age-dependent manner in the Tg2576/PS1(P264L) cortex but not in either PS1(P264L) or Tg2576 cortex. Stress-responsive MAP kinase pathways were activated in the brain of the Tg2576/PS1(P264L) AD model, and this activation was coincident with the age-dependent increase in amyloid deposition, tau phosphorylation, and loss of synaptophysin.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.22-09-03376.2002

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Mammalian Mitogen-Activated Protein Kinase Signal Transduction Pathways Activated by Stress and Inflammation
Kyriakis, J. M., & Avruch, J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.807 · Cited by 3,400
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
Gómez‐Isla, T., Hollister, R., West, H., Mui, S., Growdon, J. H., Petersen, R. C., Parisi, J. E., & Hyman, B. T. (1997) · Annals of Neurology · doi:10.1002/ana.410410106 · Cited by 1,489
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92338-8 · Cited by 1,267 · cited 2×
“The memory impairments in Alzheimer’s disease (AD) are attributable to the loss of both neurons and synapses (West et al., 1994; DeKosky et al., 1996; Gomez-Isla et al., 1997).”
BackgroundSelf-citation

Show all 61 references

Sorted by citations

Items 101–200 of 291

Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption
Ghasemi, R., Zarifkar, A., Rastegar, K., Maghsoudi, N., & Moosavi, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.036 · Cited by 69
Unloading kinesin transported cargoes from the tubulin track via the inflammatory c‐Jun N‐terminal kinase pathway
Stagi, M., Gorlovoy, P., Larionov, S., Takahashi, K., & Neumann, H. (2006) · The FASEB Journal · doi:10.1096/fj.06-6679fje · Cited by 69
Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model
Wengenack, T. M., Holasek, S. S., Montaño, C., Gregor, D. M., Curran, G. L., & Poduslo, J. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.054 · Cited by 67
Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway
Yamamoto, S., Kayama, T., Noguchi‐Shinohara, M., Hamaguchi, T., Yamada, M., Abe, K., & Kobayashi, S. (2021) · npj Science of Food · doi:10.1038/s41538-021-00084-5 · Cited by 69
N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein
Ando, K., Uemura, K., Kuzuya, A., Maesako, M., Asada-Utsugi, M., Kubota, M., Aoyagi, N., Yoshioka, K., Okawa, K., Inoue, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.158477 · Cited by 66
Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice
Holasek, S. S., Wengenack, T. M., Kandimalla, K. K., Montaño, C., Gregor, D. M., Curran, G. L., & Poduslo, J. F. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.037 · Cited by 67
The JNK pathway amplifies and drives subcellular changes in tau phosphorylation
Vogel, J. W., Anand, V. S., Ludwig, B., Nawoschik, S. P., Dunlop, J., & Braithwaite, S. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.021 · Cited by 64
Calcium-Regulated Signaling Pathways: Role in Amyloid β-Induced Synaptic Dysfunction
Xie, C.-W. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:053 · Cited by 64
Formation of Phospho-SAPK/JNK Granules in the Hippocampus Is an Early Event in Alzheimer Disease
Lagalwar, S., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000229236.98124.d8 · Cited by 62
Alpha-Linolenic Acid Impedes Cadmium-Induced Oxidative Stress, Neuroinflammation, and Neurodegeneration in Mouse Brain
Alam, S. I., Kim, M.-W., Shah, F. A., Saeed, K., Ullah, R., & Kim, M.-O. (2021) · Cells · doi:10.3390/cells10092274 · Cited by 61
Overexpression of matrix metalloproteinase-9 (MMP-9) rescues insulin-mediated impairment in the 5XFAD model of Alzheimer’s disease
Kaminari, A., Giannakas, N., Tzinia, A. K., & Tsilibary, E. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-00794-5 · Cited by 62
Mitogen-activated protein kinases and the evolution of Alzheimer’s: a revolutionary neurogenetic axis for therapeutic intervention?
Haddad, J. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.002 · Cited by 61
Huperzine a alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice
Wang, Y., Tang, X. C., & Zhang, H. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22775 · Cited by 59
Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits
Pugliese, M., Mascort, J., Mahy, N., & Ferrer, I. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0087-3 · Cited by 60
Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal
Pugazhenthi, S., Phansalkar, K., Audesirk, G. J., West, A. E., & Cabell, L. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.023 · Cited by 59
In Vivo Turnover of Tau and APP Metabolites in the Brains of Wild-Type and Tg2576 Mice: Greater Stability of sAPP in the β-Amyloid Depositing Mice
Morales‐Corraliza, J., Mazzella, M. J., Berger, J. D., Diaz, N. S., Choi, J. H. K., Levy, E., Matsuoka, Y., Planel, E., & Mathews, P. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007134 · Cited by 60
Neuroglial alterations in rats submitted to the okadaic acid-induced model of dementia
Costa, A. P., Tramontina, A. C., Biasibetti, R., Batassini, C., Lopes, M. W., Wartchow, K. M., Bernardi, C. L., Tortorelli, L. S., Leal, R. B., & Gonçalves, C. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.035 · Cited by 59
Direct and Indirect Roles of Cyclin-dependent Kinase 5 as an Upstream Regulator in the c-Jun NH2-Terminal Kinase Cascade: Relevance to Neurotoxic Insults in Alzheimer's Disease
Sun, K.-H., Lee, H., Smith, M. A., & Shah, K. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-05-0433 · Cited by 59
Repeated intra-hippocampal injection of beta-amyloid 25–35 induces a reproducible impairment of learning and memory: Considering caspase-3 and MAPKs activity
Ghasemi, R., Zarifkar, A., Rastegar, K., Maghsoudi, N., & Moosavi, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.034 · Cited by 58
Reduced cortical BACE1 content with one bout of exercise is accompanied by declines in AMPK, Akt, and MAPK signaling in obese, glucose-intolerant mice
MacPherson, R. E. K., Baumeister, P., Peppler, W. T., Wright, D. C., & Little, J. P. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00299.2015 · Cited by 58
In vitro and in vivo neuroprotective effects of cJun N-terminal kinase inhibitors on retinal ganglion cells
Kim, B.-J., Silverman, S. M., Liu, Y., Wordinger, R. J., Pang, I., & Clark, A. F. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0093-4 · Cited by 58
Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
Ghosh, S., Durgvanshi, S., Agarwal, S., Raghunath, M., & Sinha, J. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200429011823 · Cited by 57
Pharmacotherapeutic targets in Alzheimer's disease
Biran, Y., Masters, C. L., Barnham, K. J., Bush, A. I., & Adlard, P. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00595.x · Cited by 59
Amyloid-β neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity
Malinin, N. L., Wright, S., Seubert, P. A., Schenk, D., & Griswold‐Prenner, I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408237102 · Cited by 56
Targeting protein kinases for the treatment of Alzheimer's disease: Recent progress and future perspectives
Li, Z., Yin, B., Zhang, S., Lan, Z., & Zhang, L. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115817 · Cited by 54
Molecular Mechanisms for Neuronal Cell Death by Alzheimer’s Amyloid Precursor Protein-Relevant Insults
Kawasumi, M., Hashimoto, Y., Chiba, T., Kanekura, K., Yamagishi, Y., Ishizaka, M., Tajima, H., Niikura, T., & Nishimoto, I. (2002) · Neurosignals · doi:10.1159/000067424 · Cited by 53
Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer’s disease
Carola Otth, L., Mendoza‐Naranjo, A., Mujica, L., Zambrano, Á., Concha, I. I., & Maccioni, R. B. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00023 · Cited by 54
The Molecular Effects of Environmental Enrichment on Alzheimer’s Disease
Liew, A. K. Y., Teo, C. H., & Soga, T. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03016-w · Cited by 61
Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice
Ferrer, I. (2004) · Neurotoxicity Research · doi:10.1007/bf03033283 · Cited by 53
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 50
Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576
Chauhan, N. B., Siegel, G. J., & Feinstein, D. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.014 · Cited by 50
c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s Diseases
Rehfeldt, S. C. H., Majolo, F., Goettert, M. I., & Laufer, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249677 · Cited by 47
WWOX Phosphorylation, Signaling, and Role in Neurodegeneration
Liu, C., Ho, P., Lee, I.-T., Chen, Y., Chu, C., Teng, C., Wu, S., Sze, C., Chiang, M., & Chang, N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00563 · Cited by 46
Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein
Lee, K.-W., Im, J., Song, J.-S., Lee, S. H., Lee, H.-J., Ha, H.-Y., Koh, J., Gwag, B. J., Yang, S.-D., Paik, S., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.011 · Cited by 48
Activation of mitogen‐activated protein kinases in hamster brains infected with 263K scrapie agent
Lee, H., Jun, Y.-C., Choi, J., Kim, J., Carp, R. I., & Kim, Y. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03429.x · Cited by 49
Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes
Beeler, N., Riederer, B. M., Waeber, G., & Abderrahmani, A. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.07.006 · Cited by 51
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Sidiropoulou, G. A., Metaxas, A., & Kourti, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217730 · Cited by 54
Lipopolysaccharide-induced tau phosphorylation and kinase activity - modulation, but not mediation, by corticotropin-releasing factor receptors
Roe, A. D., Staup, M. A., Serrats, J., Sawchenko, P. E., & Rissman, R. A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07764.x · Cited by 49
The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD mice
Zhu, Z., Zhang, L., Elsherbini, A. M., Crivelli, S. M., Tripathi, P., Harper, C., Quadri, Z., Spassieva, S. D., & Bieberich, E. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104713 · Cited by 45
RETRACTED: The 12‐15‐lipoxygenase is a modulator of Alzheimer's‐related tau pathology in vivo
Giannopoulos, P. F., Joshi, Y. B., Chu, J., & Praticò, D. (2013) · Aging Cell · doi:10.1111/acel.12136 · Cited by 44
Retracted
Facilitation of Stress-induced Phosphorylation of β-Amyloid Precursor Protein Family Members by X11-like/Mint2 Protein
Taru, H., & Suzuki, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312007200 · Cited by 44
Activation of α7 nicotinic acetylcholine receptor alleviates Aβ1-42-induced neurotoxicity via downregulation of p38 and JNK MAPK signaling pathways
Chang, K.-W., Zong, H.-F., Ma, K., Zhai, W.-Y., Yang, W., Hu, X., Xu, J., Chen, X., Ji, S., & Qian, Y. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.09.005 · Cited by 44
Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice
Griffith, C. M., Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X., Reagan, L. P., Strader, A. D., Rose, G. M., & Patrylo, P. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180707 · Cited by 44
Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer’s disease
Fu, Y., Hu, X. S., Zheng, C., Sun, G., Xu, J., Luo, S., & Cao, P. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00438-9 · Cited by 43
P38 Activation Mediates Amyloid-β Cytotoxicity
Zhu, X., Mei, M. G., Lee, H., Wang, Y., Han, J., Perry, G. L., & Smith, M. A. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6872-x · Cited by 42
The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
Borders, A. S., de Almeida, L., Eldik, L. J. V., & Watterson, D. M. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s12 · Cited by 43
JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
Solas, M., Vela, S., Smerdou, C., Martišová, E., Martínez-Valbuena, I., Luquín, M. R., & Ramírez, M. J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00093 · Cited by 42
Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice
Chu, J., Li, J. G., Giannopoulos, P. F., Blass, B. E., Childers, W. E., Abou-Gharbia, M. A., & Praticò, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.170 · Cited by 42
Arc Regulates Transcription of Genes for Plasticity, Excitability and Alzheimer’s Disease
Leung, H.-W., Foo, G., & VanDongen, A. M. J. (2022) · Biomedicines · doi:10.3390/biomedicines10081946 · Cited by 41
p38MAPK/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration
Cardaci, S., Filomeni, G., Rotilio, G., & Ciriolo, M. R. (2010) · Biochemical Journal · doi:10.1042/bj20100503 · Cited by 42
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
Castellani, R. J., Zhu, X., Lee, H., Moreira, P. I., Perry, G. L., & Smith, M. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.5.473 · Cited by 42
Okadaic acid induces JNK activation, bim overexpression and mitochondrial dysfunction in cultured rat cortical neurons
Yoon, S.-Y., Choi, J., Yoon, J., Huh, J., & Kim, D. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.034 · Cited by 40
Alpha 1-Antichymotrypsin, an Inflammatory Protein Overexpressed in the Brains of Patients with Alzheimer’s Disease, Induces Tau Hyperphosphorylation through c-Jun N-Terminal Kinase Activation
Tyagi, E., Fiorelli, T., Norden, M., & Padmanabhan, J. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/606083 · Cited by 40
Resveratrol protects retinal ganglion cell axons through regulation of the SIRT1-JNK pathway
Wu, Y., Pang, Y., Wei, W., Shao, A., Deng, C., Li, X., Chang, H., Hu, P., Liu, X., & Zhang, X. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108249 · Cited by 40
Alzheimer's Therapeutics: Neurotrophin Domain Small Molecule Mimetics
Massa, S. M., Xie, Y., & Longo, F. M. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:323 · Cited by 39
Alzheimer’s therapeutics
Massa, S. M., Xie, Y., & Longo, F. M. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0019-1 · Cited by 39
GSTT1 is upregulated by oxidative stress through p38-MK2 signaling pathway in human granulosa cells: possible association with mitochondrial activity
Ito, M., Imai, M., Muraki, M., Miyado, K., Qin, J., Kyuwa, S., Yoshikawa, Y., Hosoi, Y., Saito, H., & Takahashi, Y. (2011) · Aging · doi:10.18632/aging.100418 · Cited by 38
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
Dai, H., Hu, W.-Y., Jiang, L.-H., Li, L., Gaung, X., & Xiao, Z. (2016) · Scientific Reports · doi:10.1038/srep27600 · Cited by 38
Tanshinone IIA Ameliorates Spatial Learning and Memory Deficits by Inhibiting the Activity of ERK and GSK-3β
Li, L., Jadoon, S. S., Liu, S.-Z., Zhang, R., Li, F., Zhang, M.-Y., Ai-Hua, T., You, Q., & Wang, P. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719837373 · Cited by 38
SuHeXiang Wan Essential Oil Alleviates Amyloid Beta Induced Memory Impairment Through Inhibition of Tau Protein Phosphorylation in Mice
Jeon, S., Hur, J., Jeong, H. J., Koo, B., & Pak, S. C. (2011) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x11009305 · Cited by 38
Low concentrations of aggregated β-amyloid induce neurite formation via the neurotrophin receptor p75
Susen, K., & Blöchl, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0671-3 · Cited by 38
XG‐102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double‐blind, placebo‐controlled, dose‐escalating study
Deloche, C., Lopez‐Lazaro, L., Mouz, S., Perino, J., Abadie, C., & Combette, J. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.20 · Cited by 37
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease
Giovannini, M. G., Cerbai, F., Bellucci, A., Melani, C., Grossi, C., Bartolozzi, C., Nosi, D., & Casamenti, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.061 · Cited by 38
Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease
Lee, E., & Chang, Y. (2025) · Cells · doi:10.3390/cells14030168 · Cited by 39
A role for mixed lineage kinases in granule cell apoptosis induced by cytoskeletal disruption
Müller, G. J., Geist, M. A., Veng, L., Willesen, M. G., Johansen, F. F., Leist, M., & Vaudano, E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03590.x · Cited by 36
Age-related decrease in constructive activation of Akt/PKB in SAMP10 hippocampus
Nie, K., Yu, J., Fu, Y., Cheng, H., Chen, F.-Y., You, Q., & Han, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.010 · Cited by 36
MLK3‐MKK3/6‐P38MAPK cascades following N‐methyl‐D‐aspartate receptor activation contributes to amyloid‐β peptide‐induced apoptosis in SH‐SY5Y cells
Zhou, F., Xu, Y., & Hou, X. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23354 · Cited by 33
Advances in the development of kinase inhibitor therapeutics for Alzheimer's disease
Savage, M. J., & Gingrich, D. E. (2009) · Drug Development Research · doi:10.1002/ddr.20287 · Cited by 33
Self-citation
Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis
Neve, R. L., & McPhie, D. L. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.008 · Cited by 33
Neuro-protective effects of aloperine in an Alzheimer’s disease cellular model
Zhao, J., Zhang, G., Li, M., Luo, Q., Leng, Y., & Liu, X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.008 · Cited by 33
Dysregulation of Mitogen-Activated Protein Kinase Signaling Pathways in Simian Immunodeficiency Virus Encephalitis
Barber, S. A., Uhrlaub, J. L., DeWitt, J. B., Tarwater, P. M., & Zink, M. C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63125-2 · Cited by 33
RETRACTED: Aβ(1–42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau
Ghribi, O., Pramoonjago, P., Herman, M. M., Spaulding, N. K., & Savory, J. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.001 · Cited by 33
Retracted
Dopamine D2 receptor agonist Bromocriptine ameliorates Aβ1-42-induced memory deficits and neuroinflammation in mice
Liu, X., Cheng, Z.-Y., Li, Y.-F., Liu, C., Wang, C., Gong, X., & He, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175443 · Cited by 32
From Fundamentals to Innovation in Alzheimer’s Disease: Molecular Findings and Revolutionary Therapies
Sighencea, M. G., Popescu, R. Ș., & Trifu, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212311 · Cited by 33
In Silico Design of Novel Tetra-Substituted Pyridinylimidazoles Derivatives as c-Jun N-Terminal Kinase-3 Inhibitors, Using 2D/3D-QSAR Studies, Molecular Docking and ADMET Prediction
Aissouq, A. E., Toufik, H., Stitou, M., Ouammou, A., & Lamchouri, F. (2019) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-019-09939-8 · Cited by 32
Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives
Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34
Psychostimulant-Induced Endoplasmic Reticulum Stress and Neurodegeneration
Go, B. S., Kim, J., Yang, J. H., & Choe, E. S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9969-0 · Cited by 33
Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies
Lachén‐Montes, M., Zelaya, M. V., Segura, V., Fernández‐Irigoyen, J., & Santamaría, E. (2017) · Oncotarget · doi:10.18632/oncotarget.18193 · Cited by 30
The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide
Ramberg, V., Tracy, L. M., Samuelsson, M., Nilsson, L. N. G., & Iverfeldt, K. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-34 · Cited by 33
Cyclin-dependent kinase 5, Munc18a and Munc18-interacting protein 1/X11α protein up-regulation in Alzheimer’s disease
Jacobs, E. H., Williams, R. J., & Francis, P. T. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.017 · Cited by 31
RETRACTED: GDNF regulates the Aβ-induced endoplasmic reticulum stress response in rabbit hippocampus by inhibiting the activation of gadd 153 and the JNK and ERK kinases
Ghribi, O., Herman, M. M., Pramoonjago, P., Spaulding, N. K., & Savory, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.002 · Cited by 31
Retracted
Hydrogen Sulfide Ameliorates Lipopolysaccharide-Induced Memory Impairment in Mice by Reducing Apoptosis, Oxidative, and Inflammatory Effects
Kshirsagar, V. V., Thingore, C., Gursahani, M., Gawali, N. B., & Juvekar, A. R. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00374-6 · Cited by 30
p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer's Disease
Dalrymple, S. A. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:295 · Cited by 30
The Interplay of Akt and ERK in Aβ Toxicity and Insulin-Mediated Protection in Primary Hippocampal Cell Culture
Ghasemi, R., Moosavi, M., Zarifkar, A., Rastegar, K., & Maghsoudi, N. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0622-6 · Cited by 28
Friedelin Attenuates Neuronal Dysfunction and Memory Impairment by Inhibition of the Activated JNK/NF-κB Signalling Pathway in Scopolamine-Induced Mice Model of Neurodegeneration
Sandhu, M., Irfan, H. M., Shah, S. A., Ahmed, M., Naz, I., Akram, M., Fatima, H., & Farooq, A. S. (2022) · Molecules · doi:10.3390/molecules27144513 · Cited by 28
Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer’s Disease
Petrov, D., Luque, M., Pedrós, I., Ettcheto, M., Abad, S., Pallàs, M., Verdaguer, E., Auladell, C., Folch, J., & Camins, A. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9522-6 · Cited by 28
Evidence of Presynaptic Localization and Function of the c-Jun N-Terminal Kinase
Biggi, S., Buccarello, L., Sclip, A., Lippiello, P., Tonna, N., Rumio, C., Marino, D. D., Miniaci, M. C., & Borsello, T. (2017) · Neural Plasticity · doi:10.1155/2017/6468356 · Cited by 27
ACS84, a novel hydrogen sulfide-releasing compound, protects against amyloid β-induced cell cytotoxicity
Liu, Y., Sparatore, A., Soldato, P. D., & Bian, J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.023 · Cited by 26
RETRACTION OF: The Influence of 5-Lipoxygenase on Alzheimer’s Disease-Related Tau Pathology: In Vivo and In Vitro Evidence
Chu, J., Li, J.-G., Ceballos‐Diaz, C., Golde, T. E., & Praticò, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.012 · Cited by 28
Retracted
Acute exercise and brain BACE 1 protein content: a time course study
Yang, A. J. T., Hayward, G. C., & MacPherson, R. E. K. (2019) · Physiological Reports · doi:10.14814/phy2.14084 · Cited by 26
Involvement of JNK in the Embryonic Development and Organogenesis in Zebrafish
Xiao, Y., Zhou, Y., Xiong, Z., Zou, L., Jiang, M., Luo, Z., Wen, S., Liu, W., Liu, S., & Li, W. (2013) · Marine Biotechnology · doi:10.1007/s10126-013-9520-5 · Cited by 25
Prion-associated Increases in Src-family Kinases
Nixon, R. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410883200 · Cited by 25
An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid β Precursor Protein Signaling
Hashimoto, Y., Toyama, Y., Kusakari, S., Nawa, M., & Matsuoka, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698092 · Cited by 26
A Tetra(Ethylene Glycol) Derivative of Benzothiazole Aniline Enhances Ras-Mediated Spinogenesis
Megill, A., Lee, T., DiBattista, A. M., Song, J. M., Spitzer, M. H., Rubinshtein, M., Habib, L. K., Capule, C. C., Mayer, M., Turner, R. S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1615-12.2013 · Cited by 24
Diabetes, Insulin and Alzheimer's Disease
Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24
Synaptic plasticity, AMPA-R trafficking, and Ras-MAPK signaling
Gu, Y., & Stornetta, R. L. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00609.x · Cited by 25
A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice
Kelliny, S., Lin, L., Deng, I. B., Xiong, J., Zhou, F. H., Al‐Hawwas, M., Bobrovskaya, L., & Zhou, X. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02338-5 · Cited by 23
Novel compound VB‐037 inhibits A&bgr; aggregation and promotes neurite outgrowth through enhancement of HSP27 and reduction of P38 and JNK‐mediated inflammation in cell models for Alzheimer's disease
Chiu, Y.-J., Hsieh, Y.-H., Lin, T.-H., Lee, G.-C., Hsiu, M.-H.-L., Sun, Y.-C., Chen, C.-M., Chang, K.-H., & Lee-Chen, G. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.021 · Cited by 21
Alzheimer's Disease and Frontotemporal Dementia: A Review of Pathophysiology and Therapeutic Approaches
Kelliny, S., Zhou, X., & Bobrovskaya, L. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70046 · Cited by 27
Aerobic exercise reduces hippocampal ERK and p38 activation and improves memory of middle‐aged rats
Cardoso, F. D. S., França, E. F., Serra, F. T., Victorino, A. B., de Almeida, A. A., Fernandes, J., Cabral, F. R., Venâncio, D. P., Arida, R. M., & da Silva, S. G. (2017) · Hippocampus · doi:10.1002/hipo.22740 · Cited by 21

Authors: Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W.
ORCID: Scott, Richard W.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2002-05-01
Volume: 22
Issue: 9
Pages: 3376-3385
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.22-09-03376.2002
PMC: PMC6758401
OpenAlex: W1558509021
Cited by: 291
References: 61
Citations by year: 2026: 2 · 2025: 9 · 2024: 6 · 2023: 11 · 2022: 10 · 2021: 8 · 2020: 8 · 2019: 15 · 2018: 8 · 2017: 8 · 2016: 16 · 2015: 9 · 2014: 14 · 2013: 9 · 2012: 6
FWCI: 12.81
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neuroscience (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, c-Jun N-terminal kinase, p38 MAPK, amyloid deposition, MAPK signaling, Tg2576 mice, amyloid precursor protein, MAPKAPK4, c-Jun, tau phosphorylation, synaptophysin, synaptic integrity, neuronal loss, hippocampal CA1
MeSH terms: Aging, Alzheimer Disease, Amyloid, Animals, Cell Count, Cerebral Cortex, Disease Models, Animal, Enzyme Activation, Hippocampus, Humans, Immunohistochemistry, Membrane Proteins, Mice, Transgenic, Neurons, Phosphorylation, Signal Transduction, Neurites, Amyloid beta-Protein Precursor, Synaptophysin, tau Proteins, Gene Targeting, Amino Acid Substitution, Mitogen-Activated Protein Kinases, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Presenilin-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks